Yale-CURE BioHaven Entrepreneurship Series Presents Optherion: "Diagnosing and Treating Age-related Macular Degeneration"
The Yale-CURE BioHaven Entrepreneurship Series continues its spring schedule with a program on Ophtherion, Inc. on Wednesday, March 19 from 4 to 5 p.m. in the Anlyan Center Auditorium, Yale School of Medicine, 300 Cedar Street. The series is organized by the Yale Office of Cooperative Research and Connecticut United for Research Excellence (CURE).
The featured speakers will be Colin Foster, the President and Chief Executive Officer of Optherion, and Amanda Hayward, the Senior Vice President, Scheer & Company, Inc.
Age-related macular degeneration (AMD) is the leading cause of blindness in people over age 60 in the developed world. Ophtherion, Inc. is a company that has begun to use groundbreaking discoveries on the genetic causes of AMD by scientists at Yale and the University of Iowa to develop diagnostics and disease-modifying therapies to prevent loss of vision in patients with AMD.
In the future, Optherion’s proprietary technologies will also be extended to the possible diagnosis and treatment of other related chronic diseases.
In October 2007, Optherion completed $37 million in start-up financing. The company has office and laboratories in New Haven, Connecticut, and on the biotechnology campus of the University of Iowa in Coralville. For further information about Optherion visit www.optherion.com.
Refreshments and networking will follow the seminar from 5 to 7 p.m. Registration is free, but advanced registration is required. To RSVP, call the Yale Office of Cooperative Research at 203-785-6209 or e-mail firstname.lastname@example.org. A flyer about all events in the series is available online. Directions to the event are available online.
Yale BioHaven Entrepreneurship Series are sponsored by the Yale Office of Cooperative Research, Connecticut United for Research Excellence (CURE), Wiggin and Dana, LLP, Elm Street Ventures, and Price Waterhouse Coopers, PC. with support from the Yale Entrepreneurial Society and the Yale Biotechnology & Pharmaceutical Society. For further information on the seminar, please contact Tracy Huang at 203-436-8096 or email@example.com.